CHPT vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ChargePoint exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and an alarming Debt/Equity ratio of 12.98. While the Price/Sales ratio is low (0.41), this is offset by catastrophic profitability metrics, including a -277.38% ROE and negative profit margins of -53.55%. The company's long-term price performance is devastating, with a 98.7% decline over five years, and insider sentiment remains bearish with zero buy transactions in the last six months. The combination of high leverage and anemic revenue growth (7.3%) suggests a high risk of insolvency or significant dilution.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
CHPT vs TSLA: Head-to-Head Comparison
This page compares ChargePoint Holdings, Inc. (CHPT) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.